SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-017190
Filing Date
2020-08-10
Accepted
2020-08-10 07:42:26
Documents
38
Period of Report
2020-08-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K navb20200809_8k.htm 8-K 20774
2 EXHIBIT 99.1 ex_198332.htm EX-99.1 21408
3 slide01.jpg GRAPHIC 40795
4 slide02.jpg GRAPHIC 138493
5 slide03.jpg GRAPHIC 72997
6 slide04.jpg GRAPHIC 70758
7 slide05.jpg GRAPHIC 82533
8 slide06.jpg GRAPHIC 79139
9 slide07.jpg GRAPHIC 78599
10 slide08.jpg GRAPHIC 71926
11 slide09.jpg GRAPHIC 56780
12 slide10.jpg GRAPHIC 65508
13 slide11.jpg GRAPHIC 89049
14 slide12.jpg GRAPHIC 71943
15 slide13.jpg GRAPHIC 67602
16 slide14.jpg GRAPHIC 72462
17 slide15.jpg GRAPHIC 83884
18 slide16.jpg GRAPHIC 82775
19 slide17.jpg GRAPHIC 79176
20 slide18.jpg GRAPHIC 78705
21 slide19.jpg GRAPHIC 53723
22 slide20.jpg GRAPHIC 72977
23 slide21.jpg GRAPHIC 59417
24 slide22.jpg GRAPHIC 80920
25 slide23.jpg GRAPHIC 83124
26 slide24.jpg GRAPHIC 90503
27 slide25.jpg GRAPHIC 67155
28 slide26.jpg GRAPHIC 48193
29 slide27.jpg GRAPHIC 68002
30 slide28.jpg GRAPHIC 51141
31 slide29.jpg GRAPHIC 52498
32 slide30.jpg GRAPHIC 62268
33 slide31.jpg GRAPHIC 53618
34 slide32.jpg GRAPHIC 67902
35 slide33.jpg GRAPHIC 59367
36 slide34.jpg GRAPHIC 69197
37 slide35.jpg GRAPHIC 105764
38 slide36.jpg GRAPHIC 40187
  Complete submission text file 0001437749-20-017190.txt   3585038
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 201087136
SIC: 2835 In Vitro & In Vivo Diagnostic Substances